Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

On March 6, 2019 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, reported that management will participate in the following healthcare investor conferences in March (Press release, Sangamo Therapeutics, MAR 6, 2019, View Source [SID1234534074]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 39th Annual Health Care Conference
Presentation Date: Tuesday, March 12th at 8:40 a.m. Eastern Time
Location: Boston, MA
Barclays 2019 Global Healthcare Conference
Presentation Date: Thursday, March 14th at 8:00 a.m. Eastern Time
Location: Miami, FL
ARM 7th Annual Cell & Gene Investor Day
Presentation Date: Thursday, March 21st at 2:45 p.m. Eastern Time
Location: New York, NY

The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.